BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 24618962)

  • 41. [More stringent requirements concerning manuscripts. Declarations of potential connections and conflicts of interest published in the Lakartidningen].
    Milerad J; Ahlberg J; Eliasson M; Fridén B; Håkansson A; Sundberg CJ; Agren H; Ostergren J
    Lakartidningen; 2002 Apr; 99(15):1662-3. PubMed ID: 12025190
    [No Abstract]   [Full Text] [Related]  

  • 42. Sponsorship, authorship, and accountability.
    Davidoff F; DeAngelis CD; Drazen JM; Nicholls MG; Hoey J; Højgaard L; Horton R; Kotzin S; Nylenna M; Overbeke AJ; Sox HC; Van Der Weyden MB; Wilkes MS
    N Engl J Med; 2001 Sep; 345(11):825-6; discussion 826-7. PubMed ID: 11556304
    [No Abstract]   [Full Text] [Related]  

  • 43. [More rigorous requirements of openness concerning clinical trials. Only manuscripts with all data freely accessible to researchers will be accepted by leading medical journals].
    Milerad J
    Lakartidningen; 2001 Oct; 98(43):4692. PubMed ID: 11715243
    [No Abstract]   [Full Text] [Related]  

  • 44. Publication bias in the anesthesiology literature.
    De Oliveira GS; Chang R; Kendall MC; Fitzgerald PC; McCarthy RJ
    Anesth Analg; 2012 May; 114(5):1042-8. PubMed ID: 22344237
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New guidelines for authors.
    Westhoff C; Bowen T
    Contraception; 2013 Jul; 88(1):1-2. PubMed ID: 23773526
    [No Abstract]   [Full Text] [Related]  

  • 46. Retrospective cohort study highlighted outcome reporting bias in UK publicly funded trials.
    Matthews GA; Dumville JC; Hewitt CE; Torgerson DJ
    J Clin Epidemiol; 2011 Dec; 64(12):1317-24. PubMed ID: 21889307
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Postpublication Metrics of Randomized Clinical Trials With and Without Null Findings.
    Murray SB; Heathers JA; Schauer RM; Griffiths S; Mitchison D; Mond JM; Nagata JM
    JAMA; 2019 May; 321(18):1825-1826. PubMed ID: 31087013
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation.
    Ross JS; Hill KP; Egilman DS; Krumholz HM
    JAMA; 2008 Apr; 299(15):1800-12. PubMed ID: 18413874
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Industry sponsorship and authorship of clinical trials over 20 years.
    Buchkowsky SS; Jewesson PJ
    Ann Pharmacother; 2004 Apr; 38(4):579-85. PubMed ID: 14982982
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Do editors live up to the Sept 10, 2001, expectations?
    Vandenbroucke JP
    Lancet; 2002 Nov; 360(9345):1605-6; author reply 1606. PubMed ID: 12443629
    [No Abstract]   [Full Text] [Related]  

  • 51. [Scientific reporting guidelines].
    Nylenna M
    Tidsskr Nor Laegeforen; 2009 Nov; 129(22):2340. PubMed ID: 19935931
    [No Abstract]   [Full Text] [Related]  

  • 52. The peer review congresses: improving peer review and biomedical publication.
    Steinbrook R
    JAMA; 2013 Nov; 310(17):1799-800. PubMed ID: 24126455
    [No Abstract]   [Full Text] [Related]  

  • 53. Sponsorship, authorship, and accountability.
    Kalman C
    Lancet; 2002 Jan; 359(9303):351-2. PubMed ID: 11830224
    [No Abstract]   [Full Text] [Related]  

  • 54. Honorary authorship in radiologic research articles: do geographic factors influence the frequency?
    Eisenberg RL; Ngo LH; Bankier AA
    Radiology; 2014 May; 271(2):472-8. PubMed ID: 24475845
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blinded by the light: Anonymization should be used in peer review to prevent bias, not protect referees.
    Shaw DM
    EMBO Rep; 2015 Aug; 16(8):894-7. PubMed ID: 26174615
    [No Abstract]   [Full Text] [Related]  

  • 56. Quality of reports of randomised trials and estimates of treatment efficacy.
    Sauerland S; Lefering R
    Lancet; 1998 Nov; 352(9139):1555-6. PubMed ID: 9820334
    [No Abstract]   [Full Text] [Related]  

  • 57. CONSORT. Consolidated Standards of Reporting Trials.
    Needleman I
    Br Dent J; 1999 Mar; 186(5):207. PubMed ID: 10205958
    [No Abstract]   [Full Text] [Related]  

  • 58. Ethical dilemmas in journal publication.
    Babalola O; Grant-Kels JM; Parish LC
    Clin Dermatol; 2012; 30(2):231-6. PubMed ID: 22330669
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Scientific data from clinical trials: investigators' responsibilities and rights.
    Polk HC; Bowden TA; Rikkers LF; Balch CM; Organ CH; Murie JA; Pories WJ; Buechler MW; Neoptolemos JP; Fazio VW; Schwartz SI; Cameron JL; Kelly KA; Grosfeld JL; McFadden DW; Souba WW; Pruitt BA; Johnston KW; Rutherford RB; Arregui ME; Scott-Conner CE; Warshaw AL; Sarr MG; Cuschieri A; MacFadyen BV; Tompkins RK
    World J Surg; 2002 Jun; 26(6):637-8. PubMed ID: 12045855
    [No Abstract]   [Full Text] [Related]  

  • 60. Industry-sponsored clinical research: a broken system.
    Angell M
    JAMA; 2008 Sep; 300(9):1069-71. PubMed ID: 18768418
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.